According to news from Democracy Now, one result of the president’s tax overhaul is that Big Pharma giant Pfizer will be “reaping a staggering $11 billion gain”.1 Although the plan was billed as a help to and for the middle class, a recent poll from Reuters shows that only 2 percent of surveyed workers say they’ve received any benefit from the tax overhaul.2

RELATED STORY:

RELATED STORY:

I’d say regardless of how you feel about democrats or republicans and the tax bill, anything that benefits Big Pharma seems like a fail to me.

Sources and References

  1. Democracy Now, January 31, 2018.
  2. Democracy Now, January 31, 2018.